LAB Deferred Revenue
Standard Biotools Inc · Deferred Revenue
LAB Deferred Revenue
Latest reported$12.02Mperiod ending
LAB Quarterly Deferred Revenue ($2.65M → $12.02M)
Quarterly deferred revenue
High-resolution chart · PNG
LAB deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 12,019,000 | |
| 13,842,000 | |
| 38,949,000 | |
| 44,108,000 | |
| 44,299,000 | |
| 17,326,000 | |
| 18,585,000 | |
| 18,322,000 | |
| 19,712,000 | |
| 20,257,000 | |
| 16,735,000 | |
| 17,175,000 | |
| 15,315,000 | |
| 15,273,000 | |
| 14,436,000 | |
| 14,978,000 | |
| 15,138,000 | |
| 15,894,000 | |
| 15,482,000 | |
| 17,157,000 | |
| 21,678,000 | |
| 14,222,000 | |
| 16,387,000 | |
| 13,436,000 | |
| 14,279,000 | |
| 12,667,000 | |
| 11,803,000 | |
| 11,938,000 | |
| 11,972,000 | |
| 12,325,000 | |
| 11,464,000 | |
| 11,511,000 | |
| 10,756,000 | |
| 10,645,000 | |
| 10,238,000 | |
| 9,877,000 | |
| 9,097,000 | |
| 9,900,000 | |
| 9,163,000 | |
| 9,724,000 | |
| 9,028,000 | |
| 9,101,000 | |
| 9,419,000 | |
| 8,179,000 | |
| 7,547,000 | |
| 7,346,000 | |
| 6,928,000 | |
| 6,630,000 | |
| 5,867,000 | |
| 5,331,000 | |
| 2,721,000 | |
| 2,807,000 | |
| 2,217,000 | |
| 1,928,000 | |
| 1,886,000 | |
| 2,134,000 | |
| 1,733,000 | |
| 1,527,000 | |
| 2,011,000 | |
| 1,818,000 | |
| 1,786,000 | |
| 1,562,000 | |
| 1,336,000 | |
| 1,490,000 | |
| 758,000 | |
| 1,412,000 | |
| 2,504,000 | |
| 2,652,000 |